British scientists have found yet another drug which could prevent blood clotting within 24 hours after being admitted to hospital.
There are beliefs that some Covid deaths could be happening due to blood clots which develop in major veins and arteries which prompted the research.
Scientists have said there is “strong real world evidence” to support giving patients blood thinners, based on a study of over 4,000 people.
A team of US and UK researchers looked at data of 4,297 Covid patients who were admitted to hospital between 1 March and 31 July 2020.
Within 24 hours of hospital admission, 3,627 patients were given prophylactic anticoagulation, and according to the peer reviewed observational study published in The British Medical Journal, there were 622 deaths within 30 days.
The scientists explained that patients who had received prophylactic anticoagulation death at 30 days was 14.3%, compared to 18.7% who did not receive the blood thinning drug.
The risk reduction is as high as 34% with a risk reduction of 4.4%, and 93% who were involved in the research were men with the average age being 68.
The scientists said, “These findings provide strong real world evidence to support guidelines recommending the use of prophylactic anticoagulation as initial treatment for patients with Covid-19 on hospital admission.”